Altaviz introduces new handheld injection platform MVI
The MVI Injector is suitable for self-contained and flow-controlled delivery of gene therapies, stem cell therapies and dermal…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Jul 21
The MVI Injector is suitable for self-contained and flow-controlled delivery of gene therapies, stem cell therapies and dermal…
12 Jul 21
The acquisition of Vectura will allow Philip Morris to access differentiated technology and pharmaceutical development expertise to offer…
23 Jun 21
The deal is expected to provide $400 million in gross proceeds for commercialisation of Pear’s three FDA-authorised products
17 Jun 21
Smiths Medical has received no reports of death or serious injury related to this issue
14 Jun 21
The partnership is also expected to see an investment by KT in NeuroSigma
31 May 21
Aptamer will assess the technology for potential incorporation into Takeda’s drug development process
27 May 21
The autoinjector device supports medication management and connects to smartphones, tablets and mobile apps via Bluetooth
19 May 21
The new facility, which will manufacture drug delivery devices, is expected to create up to 600 new jobs
05 May 21
The companies will develop and clinically validate digital therapeutic using the Alex DTx Platform
14 Apr 21
The funds will help boost commercial plans for CeQur Simplicity, a three-day wearable insulin device for injection-free bolus…